ANI Pharmaceuticals (ANIP)
Develops rare-disease therapies, niche generics, and established prescription brands.
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | ≈ 198.67% | 45.64M shares | |
|---|---|---|---|
| 315 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail | |||
| Insiders | 7.78% | 1.79M shares | |
| 16 holders · as of Sep 16, 2026 | |||
| Adds to | 206.45% | ||
22.97M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
These groups come from separate filings that can overlap, so they add to 206.45%; nothing is left for Other.
This company has 2 share classes; every stake here is a share of the whole company.
13F, as of Jun 30, 2026
315 holders · 22.82M shares · 54 new positions · 173 increased · 90 reduced · 26 closed
| Holder | Shares | % of company | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 2.96M | 12.88% | +211.2K | Aug 7, 2026 |
| Soleus Capital Management, L.P. | 867.8K | 3.78% | +47.5K | Aug 11, 2026 |
| Vanguard Capital Management LLC | 838.2K | 3.65% | +15.2K | Aug 13, 2026 |
| State Street Corp | 831.6K | 3.62% | +60.1K | Aug 7, 2026 |
| Tang Capital Management LLC | 707.5K | 3.08% | 0 | Aug 14, 2026 |
| Dimensional Fund Advisors LP | 623.5K | 2.71% | +92.3K | Aug 11, 2026 |
| American Century Companies Inc | 574.5K | 2.50% | +382.9K | Aug 12, 2026 |
| Arrowstreet Capital, Limited Partnership | 562.0K | 2.45% | −2.3K | Aug 13, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 11.30% | 2.52M | 13G | Oct 17, 2025 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Sep 15, 2026 | Nikhil Lalwanidirector, officer: PRESIDENT & CEO | Sale | 5,400 | $71.00 | 339,089 |
| Sep 14, 2026 | Meredith Cookofficer: SR. VP, GENERAL COUNSEL & SEC. | Sale | 500 | $70.79 | 73,924 |
| Sep 11, 2026 | Jeanne Thomadirector | Sale | 1,000 | $71.53 | 26,762 |
| Aug 31, 2026 | Stephen P. Careyofficer: SVP & CFO | Sale | 2,850 | $72.80 | 171,843 |
| Aug 25, 2026 | Nikhil Lalwanidirector, officer: PRESIDENT & CEO | Sale | 5,400 | $74.30 | 344,489 |
| Aug 13, 2026 | Meredith Cookofficer: SR. VP, GENERAL COUNSEL & SEC. | Sale | 500 | $75.48 | 74,424 |
| Aug 10, 2026 | Ori Gutwergofficer: SVP, GENERICS | Sale | 3,162 | $77.00 | 75,534 |
| Jul 29, 2026 | Stephen P. Careyofficer: SVP & CFO | Sale | 2,850 | $81.36 | 174,693 |
| Jul 13, 2026 | Meredith Cookofficer: SR. VP, GENERAL COUNSEL & SEC. | Sale | 500 | $81.84 | 77,390 |
| Jul 2, 2026 | Stephen P. Careyofficer: SVP & CFO | Sale | 3,313 | $86.00 | 177,543 |
House and Senate disclosures
Not reported.